Tropomyosin-related receptor kinase B at the invasive front and tumour cell dedifferentiation in gastric cancer

British Journal of Cancer

Volumn 110, Issue 12, 2014, Pages 2923-2934

  Tanaka, K ^a   Shimura, T ^a   Kitajima, T ^a   Kondo, S ^a   Ide, S ^a   Okugawa, Y ^a   Saigusa, S ^a   Toiyama, Y ^a   Inoue, Y ^a   Araki, T ^a   Uchida, K ^a   Mohri, Y ^a   Kusunoki, M ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Dedifferentiation; Gastric cancer; Prognosis; Tropomyosin related kinase B

Indexed keywords

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECEPTOR, TRKB; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84902535308     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.228     Document Type: Article

References (30)

1. Alpi'zar-Alpi'zar W, Christensen IJ, Santoni-Rugiu E, Skarstein A, Ovrebo K, Illemann M, Laerum OD (2012) Urokinase plasminogen activator receptor on invasive cancer cells: A prognostic factor in distal gastric adenocarcinoma. Int J Cancer 131: E329-E336
2. Barbacid M (1994) The Trk family of neurotrophin receptors. J Neurobiol 25: 1386-1403
3. Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO Classification of Tumours of the Digestive System. 4th edn. IARC Press: Lyon, France
4. Brown M, Sillah K, Griffiths EA, Swindell R, West CM, Page RD, Welch IM, Pritchard SA (2010) Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers. Histopathology 56: 893-899
5. Choi JS, Kim MA, Lee HE, Lee HS, Kim WH (2009) Mucinous gastric carcinomas: Clinicopathologic and molecular analyses. Cancer 115: 3581-3590
6. Dahlin DC, Beabout JW (1971) Dedifferentiation of low-grade chondrosarcomas. Cancer 28: 461-466
7. Dawson H, Koelzer VH, Karamitopoulou E, Economou M, Hammer C, Muller DE, Lugli A, Zlobec I (2014) The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome. Histopathology 64: 577-584
8. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, Peeper DS (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430: 1034-1039
9. Fujikawa H, Tanaka K, Toiyama Y, Saigusa S, Inoue Y, Uchida K, Kusunoki M (2012) High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells. J Gastroenterol 47: 775-784
10. Horcic M, Koelzer VH, Karamitopoulou E, Terracciano L, Puppa G, Zlobec I, Lugli A (2013) Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. Hum Pathol 44: 697-705
11. Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edn. Gastric Cancer 14: 101-112
12. Karamitopoulou E, Zlobec I, Kölzer V, Kondi-Pafiti A, Patsouris ES, Gennatas K, Lugli A (2013) Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer. Mod Pathol 26: 295-301
13. Karamitopoulou E, Zlobec I, Panayiotides I, Patsouris ES, Peros G, Rallis G, Lapas C, Karakitsos P, Terracciano LM, Lugli A (2011) Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer. Hum Pathol 42: 1888-1896
14. Kupferman ME, Jiffar T, El-Naggar A, Yilmaz T, Zhou G, Xie T, Feng L, Wang J, Holsinger FC, Yu D, Myers JN (2010) TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 29: 2047-2059
15. LAUREN P (1965) The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-Type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49
16. Lee J, Jiffar T, Kupferman ME (2012) A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma. PLoS One 7: E30246
17. Li Z, Oh DY, Nakamura K, Thiele CJ (2011) Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo. Cancer 117: 5412-5422
18. Lugli A, Karamitopoulou E, Zlobec I (2012) Tumour budding: A promising parameter in colorectal cancer. Br J Cancer 106: 1713-1717
19. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93: 387-391
20. Okugawa Y, Tanaka K, Inoue Y, Kawamura M, Kawamoto A, Hiro J, Saigusa S, Toiyama Y, Ohi M, Uchida K, Mohri Y, Kusunoki M (2013) Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer. Br J Cancer 108: 121-130
21. Piessen G, Messager M, Leteurtre E, Jean-Pierre T, Mariette C (2009) Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg 250: 878-887
22. Sasahira T, Ueda N, Kurihara M, Matsushima S, Ohmori H, Fujii K, Bhawal UK, Yamamoto K, Kirita T, Kuniyasu H (2013) Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma. Hum Pathol 44: 1098-1106
23. Seethala RR, Hunt JL, Baloch ZW, Livolsi VA, Leon Barnes E. Adenoid cystic carcinoma with high-grade transformation: A report of 11 cases and a review of the literature (2007) Am J Surg Pathol 31: 1683-1694. (Pubitemid 350287566
24. Smit MA, Peeper DS (2011) Zeb1 is required for TrkB-induced epithelialmesenchymal transition, anoikis resistance and metastasis. Oncogene 30: 3735-3744
25. Sobin L, Gospodarowicz M, Wittekind C. for the International Union Against Cancer (UICC) (ed) (2009) International Union Against Cancer (UICC). Histopathological Grading. TNM Classification of Malignant Tumors. 7th edn. Wiley-Liss: New York, N.Y.
26. Tanaka K, Mohri Y, Nishioka J, Kobayashi M, Ohi M, Miki C, Tonouchi H, Nobori T, Kusunoki M (2009a) Neurotrophic receptor, tropomyosinrelated kinase B as an independent prognostic marker in gastric cancer patients. J Surg Oncol 99: 307-310
27. Tanaka K, Mohri Y, Nishioka J, Ohi M, Yokoe T, Miki C, Tonouchi H, Nobori T, Kusunoki M (2009b) Neurotrophic receptor, tropomyosin-related kinase B, as a chemoresistant marker in oesophageal cancer. Clin Oncol (R Coll Radiol) 21: 362-363
28. Thiele CJ, Li Z, McKee AE (2009) On Trk-The TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res 15: 5962-5967
29. Ueno H, Kajiwara Y, Shimazaki H, Shinto E, Hashiguchi Y, Nakanishi K, Maekawa K, Katsurada Y, Nakamura T, Mochizuki H, Yamamoto J, Hase K (2012) New criteria for histologic grading of colorectal cancer. Am J Surg Pathol 36: 193-201
30. Zlobec I, Steele R, Terracciano L, Jass JR, Lugli A (2007) Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 60: 1112-1116. (Pubitemid 47612643.